中文版
- Development Path
Slide left
2023.02
Wallaby Medical phenox Obtained FDA 510k Clearance for its pRESET Thrombectomy Device
2022.09
Wallaby/phenox announces global launch of the pEGASUS HPC Stent System - the first laser-cut, open-cell stent device with antithrombogenic HPC coating technology
2022.05
Avenir® Plus Coil System Approved by NMPA
2022.04
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
2022.03
Esperance™ 6F Aspiration Catheter obtained NMPA approval
2021.12
Setup strategic partnership with Japan Lifeline to achieve a larger scale of development in the Japanese market
2021.11
Esperance™ 5F & 6F Aspiration Catheter obtained FDA 510(k) clearance
2021.09
Phase 1 of new Shanghai Xingchuang Park facility completed
2021.08
Avenir® Coil System obtained NMPA registration approval and was listed in the Innovative Medical Device Product List, China
2021.08
Signed strategic cooperation with Brainomix in Greater China, taking e-Stroke software as a crucial link in providing whole-process cerebrovascular disease solutions for Stroke clinical patients in China
2021.05
Strategic cooperation with Chinese Association of Cerebrovascular Diseases and Beijing Cerebrovascular Disease Industry Technology Innovation Strategic Alliance
2021.04
Esperance™ Distal Access Catheter Launched in China
2021.01
New Laguna Hills office opened
2020.11
Closed Series C financing from a group of leading healthcare investors
2020.08
Series B+ financing closed
2020.05
Avenir® Coil System registered with the Taiwan FDA
2020.05
Avenir® Coil System registered in Mexico
2020.04
Avenir® Coil System was registered in Israel
2019.12
The first USA sale of Avenir® Coil System
2019.12
Avenir® Coil System registered in Japan
2019.12
Setup strategic partnership with Phenox (Germany) and signed exclusive licensed distribution agreement in the United States and Europe for Avenir® Coil System
2019.09
Avenir® Coil System receives CE Mark
2019.05
Shanghai Tianxiong Road Factory expansion completed
2019.04
Completed animal study of Esperance™ Aspiration Catheter
2019.02
Qingdai Road Office completed
2018.07
Series B financing closed
2018.07
China Patent of Avenir® Coil System Series granted
2018.05
Avenir® Coil System obtained FDA 510(k) clearance
2018.04
Obtained ISO 13485 Certification
2018.03
Esperance™ Distal Access Catheter prototype sample successfully completed
2017.05
Series A financing closed
2017.01
Wallaby Shanghai Tianxiong Road Factory Complete
2016.11
Avenir® Coil System animal study successfully completed
2016.10
Angel round financing closed.
2016.07
US Provisional Patent, Application for Avenir® Coil System
2016.07
Wallaby China Office setup in Shanghai
2016.06
Functional prototype of Avenir® Coil System completed
2016.01
1st Employee joined Wallaby
2015.12
Wallaby US Setup
©2022 Wallaby Medical. All Rights Reserved | Privacy Statement 
Official Wechat
©2022 Wallaby Medical. All Rights Reserved
Privacy Statement
Official Wechat